Rheumatoid arthritis: extra-articular manifestations, immunology and the role of methotrexate

Authors

  • Tiago Tribolet de Abreu Serviço de Medicina II, Hospital Curry Cabral
  • António Panarra Serviço de Medicina II, Hospital Curry Cabral
  • Ana Ferreira Serviço de Medicina II, Hospital Curry Cabral
  • Francisco Soromenho Serviço de Medicina II, Hospital Curry Cabral
  • Manuel Vaz Riscado Serviço de Medicina II, Hospital Curry Cabral

Keywords:

rheumatoid arthritis, extra-articular manifestations, Sjõgren's syndrome, immunology, methotrexate

Abstract

Objective: To determine the extraarticular manifestations, immunology and the role of methotrexate use in a population of 67 patients with rheumatoid arthritis.

Methods: The clinical charts from all the patients in our Unit with the diagnosis of Rheumatoid Arthritis were reviewed.

Results and conclusions: 83,6% of the patients were female, with a mean age of 59,5 years. The most prevalent extraarticular manifestations were anaemia (35,8%), liver cell enzyme abnormalities (26,9%) and pulmonary fibrosis (17,9%). Sjogren's

syndrome (16,4%), antiphospholipid syndrome (3%) and morphea (3%) were associated autoimune diseases. Patients were positive for rheumatoid factor in 80,3%, for antinuclear antibodies in 26,9% and for antiphospholipid antibodies in 39,1%. Methotrexate was used in 71,4%, and was stopped in 6,3% for Jack of clinical response and in 7,9% because of toxicity.

Downloads

Download data is not yet available.

References

Kahn MF. Peltier AP. Meyer O. Piette JC. Les maladies systémiques. Flammarion. Paris. 1995.

Weatherall DJ. Ledingham JGG. Warrell DA. Oxford Textbook of Medicine. Oxford University Press. Oxford. 1996.

Kelley WN. Harris ED. Ruddy S. Sledge CB. Textbook of Rheumatology. Saunders. Philadelphia. 1993.

Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995: 21 (31) 589-604.

O'Dell JR. Triple therapy with Methotrexate, Sulfasalazine, and Hydroxychloroquine in patients with rheumatoid arthritis. Rheum Dis Clin North Arn.1998: 24 (3): 465-477.

Krerner JM. Methotrexate and emerging therapies. Rheum Ois Clin North Am 1998: 24 (3): 651-658.

Arnett FC. Edworthy SM. Bloch DA. et al. The American Rheumatism Association 1987 - revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-324.

Alarcon-Segovia D. Perez-Vazquez ME. Villa AR. Drenkard C. Cabiedes J. Preleminary classification criteria for the antiphospholipid syndrome within sustemic lupus erythematosus. Semin Arthritis Rheum 1992: 21: 275-286.

Carroll GJ. Withers K. Bayliss. The prevalence of Raynaud's syndrome in rheumatoid arthritis. Ann Rheum Dis 1981: 40: 567.

Hardon LD. Bellars L. Morley AR. Wilkinson R. Thompson M. Griffiths FD. Hematuria in rheumatoid arthritis: an association with mesangial glomerulonephritis. Ann Rheum Dis 1984: 43: 440.

Vitali C, Bombardieri S. Moutsopoulos HM et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996: 55: 116-121.´

Ewinblatt ME, Main AL. Long-term experience with low dose weekly methotrexate in rheumatoid arthritis. J Rheumatol 1990: 17 (suppl. 22): 33.

Additional Files

Published

2000-09-29

How to Cite

1.
Tribolet de Abreu T, Panarra A, Ferreira A, Soromenho F, Vaz Riscado M. Rheumatoid arthritis: extra-articular manifestations, immunology and the role of methotrexate. RPMI [Internet]. 2000 Sep. 29 [cited 2024 May 12];7(3):150-5. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1995

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>